FAROLFI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 1.964
NA - Nord America 1.646
EU - Europa 1.329
AF - Africa 126
SA - Sud America 115
OC - Oceania 1
Totale 5.181
Nazione #
US - Stati Uniti d'America 1.614
SG - Singapore 615
CN - Cina 592
IT - Italia 400
VN - Vietnam 331
DE - Germania 249
SE - Svezia 165
HK - Hong Kong 137
GB - Regno Unito 124
IN - India 109
KR - Corea 94
BR - Brasile 80
FI - Finlandia 75
RU - Federazione Russa 62
CI - Costa d'Avorio 52
IE - Irlanda 52
NL - Olanda 50
FR - Francia 41
JO - Giordania 28
BG - Bulgaria 22
CA - Canada 22
TG - Togo 22
SC - Seychelles 19
AR - Argentina 18
AT - Austria 17
ZA - Sudafrica 16
JP - Giappone 13
TR - Turchia 12
BE - Belgio 11
CH - Svizzera 11
UA - Ucraina 11
ID - Indonesia 10
PL - Polonia 10
MX - Messico 8
BD - Bangladesh 6
EE - Estonia 6
NG - Nigeria 5
CO - Colombia 4
EC - Ecuador 4
SK - Slovacchia (Repubblica Slovacca) 4
ES - Italia 3
PT - Portogallo 3
TH - Thailandia 3
TN - Tunisia 3
UZ - Uzbekistan 3
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
HR - Croazia 2
MA - Marocco 2
PE - Perù 2
PK - Pakistan 2
RO - Romania 2
SI - Slovenia 2
TW - Taiwan 2
UY - Uruguay 2
BO - Bolivia 1
BY - Bielorussia 1
GM - Gambi 1
GT - Guatemala 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MG - Madagascar 1
MT - Malta 1
MY - Malesia 1
PF - Polinesia Francese 1
PH - Filippine 1
QA - Qatar 1
RE - Reunion 1
RS - Serbia 1
SR - Suriname 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YT - Mayotte 1
Totale 5.181
Città #
Singapore 424
Ashburn 252
Hefei 202
Hong Kong 136
Santa Clara 125
Chandler 122
Fairfield 118
Munich 109
Southend 99
Seoul 94
Bologna 85
Beijing 62
Ho Chi Minh City 61
Helsinki 60
Princeton 53
Abidjan 52
Woodbridge 52
Dublin 51
Houston 50
Hanoi 48
Seattle 48
Dallas 45
Wilmington 43
Boardman 41
Dong Ket 40
Milan 38
Cambridge 36
Los Angeles 36
New York 35
Amman 28
Ann Arbor 24
Tongling 24
Lomé 22
Bengaluru 20
Berlin 19
Sofia 19
Buffalo 18
Turin 18
Nuremberg 17
Redondo Beach 17
Rome 17
Shanghai 17
Florence 16
San Diego 14
Westminster 14
Redmond 13
Des Moines 12
Guangzhou 12
Brussels 11
Orem 11
Amsterdam 10
Bern 10
Tokyo 10
Chicago 9
Montreal 9
Kuban 8
Boydton 7
Changsha 7
Chennai 7
Jinan 7
Mumbai 7
Phoenix 7
Redwood City 7
São Paulo 7
Toronto 7
Vienna 7
Yubileyny 7
Da Nang 6
Istanbul 6
Lappeenranta 6
London 6
Modena 6
Ankara 5
Calderara Di Reno 5
Casalecchio di Reno 5
Denver 5
Forlì 5
Frankfurt am Main 5
Haiphong 5
Hyderabad 5
Jakarta 5
Jyväskylä 5
Nanjing 5
Naples 5
Poplar 5
Pune 5
Rio de Janeiro 5
Shijiazhuang 5
Tianjin 5
Warsaw 5
Abeokuta 4
Bratislava 4
Brooklyn 4
Bắc Giang 4
Cesena 4
Falkenstein 4
Johannesburg 4
Olalla 4
Ottawa 4
Padova 4
Totale 3.273
Nome #
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study 270
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence 240
Adult patients with intellectual disability and epilepsy: clinical and genetic study of 114 cases 218
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. 193
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer 178
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer. 177
Identification of PET/CT radiomic signature for classification of locally recurrent rectal cancer: A network-based feature selection approach 175
A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae 174
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease 167
Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient 161
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection 153
FDG-PET assessment and metabolic patterns in Lafora disease 149
Evaluation of an Automated Module Synthesis and a Sterile Cold Kit-Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer. 142
Pictorial essay: normal variants, lesions, and pitfalls in Ga-68-PSMA PET imaging of prostate cancer. 141
68 Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer After Prostatectomy in a Multicenter Retrospective Study 137
A step towards a multidisciplinary interpretative algorithm for indeterminate adrenal lesions: the value of visual and semi-quantitative 18F-FDG PET/CT and ceCT parameters 135
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL. 131
Incidental finding of [68Ga]Ga-PSMA-avid intraductal papillary mucinous neoplasm 120
FDG-PET/CT Guided Biopsy in Angiosarcoma of Bone: Diagnosis, Staging and Beyond. 119
Single Subcutaneous Prostate Cancer Metastasis Detected by 68 Ga-PSMA PET/CT During Early Biochemical Relapse: A Case Report 117
null 113
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET. 113
[68Ga]Ga-PSMA-11 PET/CT-Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging. 110
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis 110
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study. 104
Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease 102
Male Breast Cancer Detected by 68Ga-PSMA-11 PET/CT in a Patient With Prostate Cancer With Pelvic Lymph Node Metastasis. 101
Molecular Imaging and Theranostics-A Multidisciplinary Approach 95
Evaluating [68Ga]-Ga PSMA PET/CT for Detecting Prostate Cancer Recurrence Post-High-Intensity Focused Ultrasound and Brachytherapy: A Single-Center Retrospective Study. 91
Plasma androgen receptor in prostate cancer 91
Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity 88
Lung uptake detected by 68Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case series. 84
Highlights From 2017: Impactful Topics Published in the Annals of Nuclear Medicine 81
Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence 80
The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more? 79
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy 78
Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions 76
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget. 66
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology 62
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial 52
PET imaging in urology: a rapidly growing successful collaboration. 51
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review. 50
Non-oncologic incidental uptake on FAPI PET/CT imaging 47
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review 41
The Prognostic Role of 68GA-PSMA-PET/CT in Metastatic Hormone-Sensitive Prostate Cancer: A Preliminary Analysis 39
Totale 5.301
Categoria #
all - tutte 15.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021185 0 0 0 0 0 21 4 19 39 13 7 82
2021/2022610 102 18 21 59 41 26 16 46 35 33 141 72
2022/2023638 45 79 34 46 54 49 31 57 129 14 62 38
2023/2024318 25 39 26 20 28 80 12 16 23 18 20 11
2024/20251.436 76 119 113 89 177 79 142 77 71 87 115 291
2025/20261.676 331 416 266 253 267 143 0 0 0 0 0 0
Totale 5.301